Literature DB >> 14751657

Glucose effectiveness is strongly related to left ventricular mass in subjects with stage I hypertension or high-normal blood pressure.

Pablo Stiefel1, María L Miranda, María José Rodríguez-Puras, Salvador García-Morillo, Joaquín Carneado, Encarnacion Pamies, José Villar.   

Abstract

BACKGROUND: Evidence suggests that "glucose effectiveness," (SG) or the effect of glucose per se to enhance net glucose disposal, may be at least as important as the insulin sensitivity index (SI) in the assessment of glucose tolerance. Our objective was to study the relationship of SG and SI parameters to left ventricular mass in a group of untreated, nondiabetic, and nonobese subjects recently diagnosed with stage I or high-normal blood pressure (BP).
METHODS: In this sample of subjects, among whom the expected prevalence of insulin resistance is low, we assessed SG and SI parameters using the intravenous glucose tolerance test and minimal model analysis. We also measured left ventricular mass (LVM) index and diastolic function by echocardiography.
RESULTS: We observed a strong relationship between SG and LVM index (r = -0.61, P <.0001). Patients with left ventricular hypertrophy (LVH) had lower SG than those without LVH (0.1114 +/- 0.04 v 0.2088 +/- 0.08 x 10(-1). min(-1), P <.001). In contrast, patients below the lowest quartile of the SG parameter distribution had higher LVM index (126.4 +/- 23.1 v 94.8 +/- 22.3 g/m(2), P <.001) and also had higher prevalence of LVH than the other patients (P <.0001). The SI related only to diastolic dysfunction, suggesting that SG may be an earlier marker of LVH than SI in hypertension.
CONCLUSION: In this sample of nonobese and glucose-tolerant subjects with an early stage of hypertension, SG but not SI was related to LVM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751657     DOI: 10.1016/j.amjhyper.2003.09.015

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

1.  Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart.

Authors:  J R Payne; K I Eleftheriou; L E James; E Hawe; J Mann; A Stronge; P Kotwinski; M World; S E Humphries; D J Pennell; H E Montgomery
Journal:  Heart       Date:  2006-06-27       Impact factor: 5.994

2.  Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction.

Authors:  Monika K Duda; Karen M O'Shea; Biao Lei; Brian R Barrows; Agnes M Azimzadeh; Tracy E McElfresh; Brian D Hoit; Willem J Kop; William C Stanley
Journal:  J Card Fail       Date:  2008-05       Impact factor: 5.712

Review 3.  Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.

Authors:  William C Stanley; Erinne R Dabkowski; Rogerio F Ribeiro; Kelly A O'Connell
Journal:  Circ Res       Date:  2012-03-02       Impact factor: 17.367

Review 4.  Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.

Authors:  Naveen Sharma; Isidore C Okere; Monika K Duda; David J Chess; Karen M O'Shea; William C Stanley
Journal:  Cardiovasc Res       Date:  2006-11-11       Impact factor: 10.787

5.  Profile of cardiovascular risk factors and mortality in patients with symptomatic peripheral arterial disease.

Authors:  Silméia Garcia Zanati; Guilherme Grisi Mouraria; Luiz Shigero Matsubara; Mariângela Giannini; Beatriz B Matsubara
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.